Companies / Saudi Arabia
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Private Healthcare On The March
February 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Saudi Arabia's public healthcare spending should fall to 50% of total expenditure over the next three years as the new private medical scheme for expatriate workers comes into effect. The private sector's contribution to drug spending should also rise to 70%. Presently, the state accounts for between 35-40% of drug purchases, primarily through large tenders, although this will fall as insurance fosters growth in the private pharmacy